Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Genomics and Personalized Health -Large-Scale Applied Genomics Res Projects

University of British Columbia

$2,800,000.00

Silent Genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations.

FY 2017-18

Summary
Indigenous populations face unique health challenges, inequities, and barriers to healthcare in Canada and around the world. As such, they typically have poorer health outcomes than do non-Indigenous groups. While genomics (the study of the complete set of human genes) has advanced health care by allowing medical treatments to be tailored to the specific needs of individual patients (‘precision medicine’), this ‘genomics revolution’ is also contributing to health inequities. In particular, compared to what is becoming routinely available to other Canadians, Indigenous populations often have little or no access to genomic technologies and the research that drives them. This has created a ‘genomic divide’, a key component of which is the lack of background genetic variation data for Indigenous populations. This prevents accurate diagnosis because the reference data are needed when multi-gene and exome (entire genome) testing panels are used. Notably, these genomics resources are silent with respect to First Nations (FN), Inuit and Métis peoples (collectively our Canadian Indigenous populations). Silent Genomes will address the genomic divide by reducing access barriers to diagnosis of genetic disease in Indigenous children. With our First Nations, Inuit and Métis partners we will: 1) Establish processes, through an Indigenous lens, for safe governance of biological samples and genome data in the Silent Genomes project, which will lead to broader policy. 2) Address barriers to accessing genetic/genomic health care and bring genomic testing to at least 200 Indigenous children with suspected genetic disorders. 3) Develop an Indigenous Background Variant Library (IBVL) of genetic variation from a diverse group of 1500 FN Canadians and assess improvement in diagnosis for referred children. 4) Assess effectiveness of the IBVL to lower health care costs and plan for long term use of IBVL for Canadian Indigenous children and adults needing genetic/genomic health care.
Program
Genomics and Personalized Health -Large-Scale Applied Genomics Res Projects
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
378643
Name
Arbour Laura T
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Genome Canada (Ottawa, Ontario); Illumina Inc. (San Diego, CA)
Instname2
Genetics
Prcname2
Special Cases
Projecttitle
Silent Genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations.
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$2,800,000
Cihrequipment2
$0
Programname2
Genomics and Personalized Health -Large-Scale Applied Genomics Res Projects
Keyworddelim
Genetic Diseases
Abstract
Indigenous populations face unique health challenges, inequities, and barriers to healthcare in Canada and around the world. As such, they typically have poorer health outcomes than do non-Indigenous groups. While genomics (the study of the complete set of human genes) has advanced health care by allowing medical treatments to be tailored to the specific needs of individual patients (‘precision medicine’), this ‘genomics revolution’ is also contributing to health inequities. In particular, compared to what is becoming routinely available to other Canadians, Indigenous populations often have little or no access to genomic technologies and the research that drives them. This has created a ‘genomic divide’, a key component of which is the lack of background genetic variation data for Indigenous populations. This prevents accurate diagnosis because the reference data are needed when multi-gene and exome (entire genome) testing panels are used. Notably, these genomics resources are silent with respect to First Nations (FN), Inuit and Métis peoples (collectively our Canadian Indigenous populations). Silent Genomes will address the genomic divide by reducing access barriers to diagnosis of genetic disease in Indigenous children. With our First Nations, Inuit and Métis partners we will: 1) Establish processes, through an Indigenous lens, for safe governance of biological samples and genome data in the Silent Genomes project, which will lead to broader policy. 2) Address barriers to accessing genetic/genomic health care and bring genomic testing to at least 200 Indigenous children with suspected genetic disorders. 3) Develop an Indigenous Background Variant Library (IBVL) of genetic variation from a diverse group of 1500 FN Canadians and assess improvement in diagnosis for referred children. 4) Assess effectiveness of the IBVL to lower health care costs and plan for long term use of IBVL for Canadian Indigenous children and adults needing genetic/genomic health care.
Competitiondate
201710
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Arbour, Laura T
Approvedterm
4 ans 0 mois
Cihrcontribution2
Inst of Indigenous Health~ $1,250,000~ $0~Major Initiatives #3~ $1,550,000~ $0~